Tarnagulla Ventures

Tarnagulla Ventures is a venture capital firm specializing in early-stage investments within global healthcare and life science. Based in Melbourne, Australia, the firm provides strategic capital and intellectual expertise to companies developing therapeutics. Their investment focus includes breakthrough technologies, particularly in small molecule, protein, and cell-based approaches.

William and Natalie McNamee manage the firm, with Natalie having served as a Director since at least 2015. Their foundational insight emphasizes concentrated, long-term partnerships, committing both financial and intellectual capital. This approach leverages their extensive experience gained from investing in and founding life science companies.

Tarnagulla Ventures backs early-stage businesses with innovative life science technologies poised for commercialization. The firm dedicates itself to supporting portfolio companies with strong strategic guidance, nurturing their development. Their long-term vision aims to advance promising medical technologies, particularly into Australian and US markets, ultimately improving global patient outcomes.